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Abstract
Background: Although severe malaria is an important cause of mortality among children in Burkina Faso, data on
community-acquired invasive bacterial infections (IBI, bacteremia and meningitis) are lacking, as well as data on the
involved pathogens and their antibiotic resistance rates.
Methods: The present study was conducted in a rural hospital and health center in Burkina Faso, in a seasonal malaria
transmission area. Hospitalized children (,15 years) presenting with T$38.0uC and/or signs of severe illness were enrolled
upon admission. Malaria diagnosis and blood culture were performed for all participants, lumbar puncture when clinically
indicated. We assessed the frequency of severe malaria (microscopically confirmed, according to World Health Organization
definitions) and IBI, and the species distribution and antibiotic resistance of the bacterial pathogens causing IBI.
Results: From July 2012 to July 2013, a total of 711 patients were included. Severe malaria was diagnosed in 292 (41.1%)
children, including 8 (2.7%) with IBI co-infection. IBI was demonstrated in 67 (9.7%) children (bacteremia, n = 63; meningitis,
n = 6), 8 (11.8%) were co-infected with malaria. Non-Typhoid Salmonella spp. (NTS) was the predominant isolate from blood
culture (32.8%), followed by Salmonella Typhi (18.8%), Streptococcus pneumoniae (18.8%) and Escherichia coli (12.5%). High
antibiotic resistance rates to first line antibiotics were observed, particularly among Gram-negative pathogens. In addition,
decreased ciprofloxacin susceptibility and extended-spectrum beta lactamase (ESBL) production was reported for one NTS
isolate each. ESBL production was observed in 3/8 E. coli isolates. In-hospital mortality was 8.2% and case-fatality rates for IBI
(23.4%) were significantly higher compared to severe malaria (6.8%, p,0.001).
Conclusions: Although severe malaria was the main cause of illness, IBI were not uncommon and had higher case-fatality
rates. The high frequency, antibiotic resistance rates and mortality rates of community acquired IBI require improvement in
hygiene, better diagnostic methods and revision of current treatment guidelines.
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Introduction
Malaria remains a major cause of mortality in children in most
sub-Saharan African countries, despite decreasing incidence rates
[1]. Community-acquired invasive bacterial infections (IBI) such as
bacteremia and bacterial meningitis also contribute to the under-5
mortality in sub-Saharan Africa [2,3], although exact data are
lacking in many areas. Severe malaria and IBI present with similar
symptoms [4,5] precluding differential diagnosis on clinical
grounds and leading to an overdiagnosis of malaria [6] and
ignorance of IBI. In Burkina Faso, a West African country with
seasonal malaria transmission, malaria is reported to be respon-
sible for 55% of deaths at district level [7], but data on frequency
of IBI, pathogens and susceptibility patterns are hardly available
due to a lack of diagnostic microbiology facilities. We conducted a
prospective observational study in order to assess proportions of
severe malaria and community-acquired IBI among children
admitted to a rural hospital and health center in Burkina Faso. In
addition, we determined the causative bacteria and their antibiotic
resistance patterns and assessed case-fatality rates of both IBI and
severe malaria.
Methods
Study site
The survey was conducted at the district hospital Centre
Me´dical avec Antenne chirurgicale (CMA) Saint Camille of
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Nanoro and the health center Urbain (with inpatient beds), both
situated in Nanoro, Burkina Faso. Nanoro is located in a rural area
in the Center-West region of the country, approximately 90 km
west of the capital Ouagadougou. The health district of Nanoro
comprises approximately 153,259 inhabitants of whom 35,159
(22.9%) are children ,5 years of age [8]. In Nanoro there is
hyperendemic malaria transmission from July – November,
corresponding to the rainy season (June – October). Meningitis
epidemics may occur in the hot, dry season (February – April), the
last dating from 2009, after which a mass vaccination campaign
against Neisseria meningitidis A was performed [7]. Pneumococcal
and meningococcal vaccines were not included in the national
extended program of immunization (EPI) at the time of the study
period. Vaccination against Haemophilus influenzae type b was
introduced into EPI in January 2006 and the estimated coverage
of immunization was 95.2% in 2011 [8]. In 2010, the overall
under-5 mortality rate in Burkina Faso was 129/1000 life-births
and 142/1000 life-births in the Center-West region [7]; HIV-
prevalence was 1.2% among women 15–49 years and 0.76%
among pregnant women [7].
Study population and procedures
All admitted children ,15 years of age presenting with axillary
temperature $38.0uC or clinical signs of severe illness were
enrolled, including respiratory distress, prostration, altered con-
sciousness, convulsions, clinical jaundice, hypothermia, signs of
shock or severe malnutrition (weight for height score ,70%
according to national guidelines or kwashiorkor) or with severe
anemia (hemoglobin ,5 g/dl). Medical history, including prior
antibiotic (48 h) and antimalarial (2 weeks) treatment, physical
examination and outcome of febrile episode (died, referred,
discharged) were registered on a standardized form by trained
study nurses. Venous blood samples for blood culture, malaria
diagnosis, full blood count and blood glucose levels were collected
from all participants by trained study staff using aseptic
techniques. Lumbar puncture was performed in case of suspicion
of cerebral malaria and/or bacterial meningitis, based on the
decision of the attending health care worker. Decision for HIV
testing or other additional testing was left to the discretion of
attending health staff. Treatment decisions were made by the
attending health staff according to national guidelines: quinine IV
for severe malaria, ampicillin + gentamicin for neonatal infections
and ceftriaxone for suspected sepsis or meningitis in older children.
Laboratory results were provided instantly to guide treatment
decisions.
Laboratory procedures
All laboratory analysis were performed at the Clinical Research
Unit of Nanoro (CRUN) which is located on the compound of
CMA. Samples were submitted within 15 minutes after collection.
Thick and thin blood films were stained with 3% Giemsa
solution (pH 7.2), examined for presence of Plasmodium species
according to standard procedures [9] and results were expressed as
asexual parasites per microliter using the patient’s white blood cell
(WBC) count. Every slide was read by two experienced
microscopists, and in case of discrepant results (positive vs.
negative, different Plasmodium species, difference in parasite density
.Log10 or ratio .2 in case of parasite density #400/ml and
.400/ml respectively) by a third experienced microscopist. A
selection of slides (5%) was re-read by an expert microscopist
whose results were considered conclusive.
The malaria rapid diagnostic test (RDT) recommended by the
national malaria control program, SD Bioline Pf (Standard
Diagnostics, Hagal-Dong, Korea) detecting P. falciparum-specific
histidine-rich protein-2 (PfHRP2), was performed on EDTA blood
samples according to the manufacturers’ instructions.
In all children, 1–3 ml of venous blood was collected into a
pediatric blood culture bottle (BD BACTEC Peds PlusTM/F,
Becton Dickinson and Company, Sparks, Maryland, USA). A
subset of blood culture bottles was weighed before and after blood
inoculation to determine the amount of blood collected. All blood
culture bottles were incubated in a BACTEC 9050 instrument
(Becton Dickinson) for a total of 5 days. If flagged for growth they
were Gram stained, subcultured on Eosin-Methylene blue (EMB)
agar and 5% Sheep Blood agar (bioMe´rieux, Marcy-l’Etoile,
France) and incubated at 35–37uC for 24 hours in atmospheric
conditions and at 5% CO2 respectively. Isolates were identified to
the species level by standard biochemical methods and antibiotic
susceptibility testing was performed by disk diffusion according to
CLSI criteria [10] or in case of assessment of minimal inhibitory
concentration (MIC) values by E-test macromethod (bioMe´rieux)
[10]. For Salmonella spp., multidrug resistance (MDR) was defined
as resistance to the first-line antibiotics ampicillin, chloramphen-
icol and trimethoprim-sulfamethoxazole (TMP-SMX); reduced
fluoroquinolone susceptibility (further referred to as decreased
ciprofloxacin susceptibility, DCS) was defined as resistance to
nalidixic acid [10] and/or MIC-values for ciprofloxacin
.0.06 mg/ml [11]. Enterobacteriaceae resistant to cephalosporins
were tested for Extended Spectrum Beta-Lactamase (ESBL)
production by combined double-disk method (Rosco Diagnostica,
Taastrup, Denmark) [10]. For Enterobacteriaceae, no breakpoints
have been published for azithromycin susceptibility, however
EUCAST V 3.1. [11] suggests treatment of infections with
Salmonella Typhi at MIC-values #16 mg/l and recently this value
has been proposed as an epidemiological cutoff value for wild-type
Salmonella spp. [12]. Non-fragile clinically significant organisms
were shipped on tryptic soy agar (TSA) at room temperature to the
Institute of Tropical Medicine, Antwerp, where identification and
antibiotic susceptibility testing were confirmed. Shigella spp. and a
subset of Salmonella spp. isolates was confirmed at the National
Reference Laboratory for Salmonella and Shigella (Institute of Public
Health, Brussels) by slide agglutination with commercial mono-
specific antisera (Sifin, Berlin, Germany), following the Kauff-
mann-White scheme [13].
Cerebrospinal fluid (CSF) was assessed for its aspect, cell count,
Gram stain and culture. The CSF leucocyte count was assessed in
a Nageotte counting chamber at6400 magnification, and if $50
WBC/ml were counted a thin film was prepared and stained with
methylene blue to count the percentage of neutrophils and
lymphocytes. For culture, 1 to 2 drops of CSF were inoculated
onto blood agar and chocolate blood agar supplemented with
IsovitalexTM (Becton Dickinson) and incubated at 35–37uC at 5%
CO2 for 48 hours. Any bacterial growth observed was further
processed by standard microbiological techniques. All CSF
samples were assessed by latex agglutination testing for Haemophilus
influenzae b, Streptococcus pneumoniae, Streptococcus group B, Neisseria
meningitidis and Escherichia coli K1 (PastorexTM Meningitis, BioRad,
Marnes-la-Coquette, France). In addition if N. meningitidis was
identified serotyping was performed (BioRad or Becton Dick-
inson).
Full blood counts were assessed using Sysmex XS1000i (Sysmex
Corporation, Kobe, Japan).
For determination of glucose levels full blood was collected on
NaF tubes and processed by Flexor Junior (Vital Scientific,
Netherland). Screening for HIV was performed at the HIV center
on the CMA compound according to national guidelines by the
rapid diagnostic test DetermineTM HIV-1/2 (Alere Medical Co.,
Ltd, Chiba, Japan) and in case positive the SD Bioline HIV-1/2
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3.0 (Standard Diagnostic INC, Kyonggi-do, Korea) was per-
formed.
Case definitions
Fever was defined as axillary temperature $37.5uC or reported
history of fever in the past 48 hours.
Malaria was defined as the presence of asexual P. falciparum
parasites confirmed by microscopy.
Severe malaria was defined as microscopically confirmed
malaria and fulfillment of at least one of the WHO clinical or
laboratory criteria of severe malaria [14] with slight adaptations:
respiratory distress was defined as abnormal deep breathing,
subcostal retraction or tachypnea according to age [15]; shock was
defined as an abnormal low systolic blood pressure according to
age [15], or a combination of temperature gradient (warm trunk
and cold extremities) and capillary refill .3 seconds.
Cerebral malaria was defined as severe falciparum malaria with
coma (Glasgow coma scale ,11 or Blantyre coma score ,3) or
convulsions in the past 24 hours ($2 or postictal phase $30
minutes) and exclusion of bacterial meningitis or hypoglycemia
alone (prompt recovery of consciousness after glucose infusion) as
cause of symptoms [14].
IBI was defined as bacteremia and/or bacterial meningitis.
Bacteremia was defined as the growth of clinical significant
organisms from blood culture. Non-pathogenic bacteria or skin
flora were considered contaminants, including coagulase-negative
Staphylococci, Bacillus spp. and Micrococcus spp.
Bacterial meningitis was defined as i) cerebrospinal fluid (CSF)
culture grown with an organism of known clinical significance, or
ii) CSF white blood cell count .10/ml with on Gram stain slides
the presence of organisms of known clinical significance, or iii)
CSF white blood cell count .10/ml and blood culture grown with
an organism of known causative role in meningitis or iv) positive
latex agglutination. Probable meningitis was defined as a child
with clinical signs of meningitis, in whom no lumbar puncture had
been performed and a bacteria known to be a causative agent in
meningitis was isolated from blood culture.
Data management and analysis
Clinical and laboratory data was double entered in Epi Info
version 3.5.3. Statistical analysis was done with Stata 11 (Stata
Corp., College Station, TX, USA).
Categorical data were assessed for significance using the chi-
square test or Fisher exact test as appropriate. The Wilcoxon rank
sum test was used for non-parametric data. Case-fatality rates
(CFR) were calculated as proportions of children who died within
a specified disease group. Only participants for whom the final
hospital outcome was known (discharge or death) were included in
the denominator of CFR calculations, referred patients were
excluded.
Ethics statement
The study was conducted according to the principles expressed
in the Declaration of Helsinki and was approved by the national
ethics committee of Burkina Faso, the institutional review board of
the Institute of Tropical Medicine, Antwerp and the ethics
committee of the University Hospital of Antwerp. Written
informed consent was given by all parents or guardians of children
enrolled.
Results
Patients included
From July 2012 to July 2013, a total of 1134 children were
admitted to the hospital, 337 were considered non-eligible and
another 177 eligible children were not included for various reasons
(not proceeding to study nurse, no blood sampling, refusal to
provide informed consent). In total 711 admitted children were
included: 607 at the hospital and another 104 children at the
health center. For age, gender and outcome, there were no
significant differences (p.0.05) between included and eligible non-
included patients, however, recorded axillary temperature was
significantly higher among included patients (p,0.001).
Demographic data, clinical features and laboratory results of the
children included are displayed in Table 1. Children were
included because of axillary temperature $38.0uC (n= 196), signs
of severe illness with fever (n = 494) or without fever (n = 21).
Lumbar puncture was performed in 19 children. Six children were
known as HIV-positive at enrolment and an additional two (out of
five tested) were newly diagnosed with HIV infection at inclusion.
Severe malaria
In 378 children (53.2%) malaria was confirmed microscopically.
In total 292 children (41.1%) fulfilled the diagnosis of severe
malaria, of whom 48 children (16.4%) had cerebral malaria and
136 (46.6%) severe malaria anemia (Table 2), including 13
children who had both cerebral malaria and severe anemia.
Severe malaria was more common among children aged 1–5 years
than those ,1 and .5 years (both p,0.001).
Parasite density was not significantly different for those fulfilling
criteria of severe malaria (median 38,319/ml, range 25–702,500)
and those not (48,544/ml, range 129–235,980, p=0.799), neither
when stratified by prior antimalarial treatment.
Of note, a positive malaria RDT was observed in 137 children
with negative microscopy, among which 106 (77.4%) had at least
one clinical or laboratory sign of severe malaria. Of them, 69.8%
(74/106) reported previous antimalarial treatment, significantly
higher compared to children with microscopically confirmed
severe malaria (36.6%, 107/292, p,0.001).
Invasive bacterial infections
Bacteremia was found in 63 (8.9%) children (Table 2), while
contaminants were grown in another 27 (3.7%) samples collected.
In one blood culture, two pathogens were isolated resulting in a
total of 64 clinically significant isolates. Proportions of bacteremia
were highest among neonates (20.0%) and children $5 years of
age (15.8%). Pathogens most frequently isolated were non-typhoid
Salmonella spp. (NTS, 32.8%), Salmonella Typhi (18.8%) Streptococcus
pneumoniae (18.8%) and Escherichia coli (12.5%) (Table 3). NTS
comprised Salmonella Typhimurium (n= 12), Salmonella Enteritidis
(n = 8) and Salmonella Telelkibir (n = 1). E. coli, NTS and Salmonella
Typhi were the most frequently isolated pathogens among
children ,1 year of age, 1–5 years and $5 years of age
respectively (Table 3).
The median (interquartile range) blood volume per blood
culture vial sampled was 0.8 ml (0.3–1.2) and 2.1 ml (1.1–3.0) for
children ,2 months and $2 months of age respectively. In 15/
170 (8.8%) and 10/170 (5.9%) children blood culture bottles were
under-filled (,0.5 ml) and overfilled (.5.0 ml) respectively.
Bacterial meningitis was confirmed in 6/19 (31.6%) children for
whom lumbar puncture was performed; pathogens were Strepto-
coccus pneumoniae (n = 3), Neisseria meningitidis W135 (n= 1), Hae-
mophilus influenzae (n = 1) and Klebsiella pneumoniae (n = 1). There
were five additional children with probable meningitis who had
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S. pneumoniae (n = 4) and N. meningitidis W135 (n = 1) isolated from
blood cultures.
Co-infections of severe malaria and invasive bacterial
disease
Distribution of positive microscopy, RDT and IBI among
children included are displayed in Figure 1. P. falciparum parasites
were present in 7/63 (11.1%) and 1/6 (16.7%) children with
bacteremia and meningitis respectively. Conversely, among the
children with severe malaria 8/292 (2.7%) had IBI. No significant
difference in parasite densities between children with severe
malaria (median 38,319/ml, range 25–702,500) and severe
malaria/IBI co-infection (79,365.5/ml, range 271–338,000) was
observed (p=0.5).
The RDT was positive in 30/63 (47.6%) children with
bacteremia and was significantly more frequent among children
with NTS (17/21, 81.0%) compared to children with other
pathogens isolated (13/42, 31.0%, p,0.001).
Proportions of malaria and invasive bacterial infections
The proportion of severe malaria per month ranged from
0.0%–62.7% among all children included with a peak from
August to October (Figure 2), while the proportion of IBI ranged
from 0.0%–24.1% per month with a peak in November – January
after the rainy season, mainly due to a high number of NTS
infections (62.5%, 15/24 bacteremia cases), and a smaller increase
in May.
Table 1. Demographic, clinical and laboratory characteristics upon admission.
All (n = 711) Hospital (n = 607) Health center (n =104)
Female sex, n (%) 318 (44.7) 264 (43.5) 54 (51.9)
Age, median months (IQR) 19 (10–36) 18 (9–34) 28.5 (14–65)
Axillary temperature $38.0uC 507 (71.3) 410 (67.5) 97 (93.3)
Pretreatment with antimalarials, n (%) 305 (42.9) 245 (40.4) 60 (57.7)
Pretreatment with antibiotics, n (%) 199 (28.0) 174 (28.7) 25 (24.0)
Clinical features upon admission
Altered consciousness 33 (4.6) 28 (4.6) 5 (4.8)
Coma, n (%) 23 (3.2) 18 (3.0) 5 (4.8)
Convulsions, n (%) 55 (7.7) 44 (7.2) 11 (10.6)
Prostration, n (%) 304 (42.8) 262 (43.2) 42 (40.4)
Respiratory distress, n (%) 221 (31.1) 172 (28.3) 49 (47.1)
Shock 48 (6.8) 40 (6.6) 8 (7.7)
Jaundice, n (%) 30 (4.2) 30 (4.9) 0
Hemoglobinuria, n (%) 6 (0.8) 5 (0.8) 1 (1.0)
Severe malnutrition*, n (%) 85 (12.7) 80 (13.7) 5 (5.9)
Laboratory features upon admission
Severe anemia (,5 g/dl), n (%) 191 (26.9) 186 (30.6) 5 (4.8)
Hypoglycemia (,2.2 mmol/l), n (%) 36 (5.1) 30 (4.9) 6 (5.8)
Hyperparasitemia (.250,000/ml) 22 (3.1) 16 (2.6) 6 (5.8)
Hb = hemoglobin IQR = interquartile range, *For 670 children data on severe malnutrition known.
doi:10.1371/journal.pone.0089103.t001
Table 2. Severe malaria and invasive bacterial infections by age group.
All ,1 m 1–11 m 12–23 m 24–59 m $60 m
n=711 n=15 n=195 n=206 n=196 n=99
Severe malaria*, n (%) 292 (41.1) 62 (31.8) 101 (49.0) 101 (51.5) 28 (28.3)
Cerebral malaria, n (%) 48 (6.8) 7 (3.6) 16 (7.8) 22 (11.2) 3 (3.0)
Severe anemia, n (%) 136 (19.1) 40 (20.5) 47 (22.8) 46 (23.5) 3 (3.0)
IBI1, n (%) 67 (9.2) 3 (20.0) 15 (7.7) 20 (9.7) 13 (6.6) 16 (16.2)
Bacteremia, n (%) 63 (8.9) 3 (20.0) 14 (7.2) 18 (8.7) 13 (6.6) 15 (15.2)
Confirmed + probable meningitis, n (%) 6+5 (1.5) 0+1 (6.7) 1+0 (0.5) 3+1 (1.9) 0+1 (0.5) 2+2 (4.0)
Co-infection IBI/malaria, n (%) 8 (1.1) 1 (6.7) 1 (0.5) 3 (1.5) 3 (1.5)
IBI = invasive bacterial infection, m = months.
*Including those with IBI co-infection, 1Including those with malaria co-infection.
doi:10.1371/journal.pone.0089103.t002
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Antibiotic resistance patterns of bacterial pathogens
Table 4 displays the antibiotic resistance rates of the Enterobac-
teriaceae: 19/21 NTS isolates were MDR, of them one Salmonella
Typhimurium was in addition ESBL producing and one Salmonella
Enteritidis isolate showed DCS (ciprofloxacin MIC-value 0.25 mg/
ml, nalidixic acid MIC-value .256 mg/ml). All other NTS isolates
were susceptible to ciprofloxacin (MIC-values #0.023 mg/ml).
Salmonella Telelkibir was susceptible to all antibiotics tested.
Among the Salmonella Typhi isolates, 10/12 (83.3%) were resistant
to both chloramphenicol and TMP-SMX but all were susceptible
to ampicillin and ciprofloxacin (MIC-values #0.008 mg/ml).
Shigella flexneri was resistant to ampicillin, chloramphenicol and
TMP-SMX, Shigella dysenteriae was resistant to ampicillin and
TMP-SMX. All NTS, Salmonella Typhi and Shigella isolates were
susceptible to azithromycin (MIC-values #6.0, #2.0 and
#1.0 mg/ml respectively). Three E. coli isolates were confirmed
ESBL producers and co-resistant to ciprofloxacin, two of them
were also co-resistant to gentamicin. No resistance to the
carbapenem antibiotics tested was detected.
All S. pneumoniae isolates (n = 11, isolated from blood) were
susceptible to ceftriaxone (MIC values #0.047 mg/ml in 10/11
and 0.19 mg/ml in the remaining one) and 10/11 were susceptible
to penicillin (MIC-values #0.032 mg/ml in 9/10 isolates and
0.064 in one). The remaining isolate had MIC-values (0.094 mg/
ml) above the CLSI meningitis susceptibility breakpoint (0.06 mg/
ml). All S. pneumoniae isolates were susceptible to erythromycin but
most 9/11 (81.8%) were resistant to TMP-SMX. The N.
meningitidis isolates were susceptible to penicillin (MIC-values
Table 3. Clinically significant organisms isolated from blood culture and age-specific frequencies.
All ,1 m 1–11 m 12–23 m 24–59 m $60 m
Age in months, median
(IQR)
All pathogenic bacteria 64 3 14 18 13 16 21 (9–54)
Non-typhoid Salmonella 21 (32.8) 5 (35.7) 8 (44.4) 6 (46.2) 2 (12.5) 19 (10–36)
Salmonella Typhi 12 (18.8) 1 (5.6) 3 (23.1) 8 (50.0) 75.5 (45–114)
Streptococcus pneumoniae 12 (18.8) 1 (33.3) 3 (21.4) 5 (27.8) 2 (15.4) 1 (6.3) 12.5 (8.5–25)
Escherichia coli 8 (12.5) 1 (33.3) 5 (35.7) 1 (7.7) 1 (6.3)* 7.5 (4–16.5)
Staphylococcus aureus 3 (4.7) 1 (7.1) 1 (6.3)
Shigella spp. 2 (3.1) 1 (5.6) 1 (7.7) 1 (6.3)
Neisseria meningitidis 2 (3.1) 1 (5.6) 1 (6.3)
Haemophilus influenzae 1 (1.6) 1 (6.3)
Streptococcus pyogenes 1 (1.6) 1 (33.3)
Aerococcus viridans 1 (1.6) 1 (5.6)
Leuconostoc 1 (1.6) 1 (6.3)*
Data displayed are numbers and percentages of clinically significant bacteria isolated.
m= months, IQR = interquartile range.
*In one patient 2 pathogens were isolated (E. coli and Leuconostoc).
doi:10.1371/journal.pone.0089103.t003
Figure 1. Numbers of children with positive microscopy, RDT
and IBI. TBF, RDT and IBI results for all children (n = 711), 169 children
tested negative on all three items. Areas in Venn-diagram approximately
to scale. TBF = thick blood film, RDT = rapid diagnostic test, IBI =
invasive bacterial infection, SM = severe malaria, UM = uncomplicated
malaria.
doi:10.1371/journal.pone.0089103.g001
Figure 2. Distribution of severe malaria (SM) and invasive
bacterial infection (IBI) by month. IBI = invasive bacterial infection,
SM = severe malaria, RDT-SM = signs of severe malaria with negative
microscopy and positive RDT, UM = uncomplicated malaria, Other = all
other children included not fulfilling criteria of SM or IBI.
doi:10.1371/journal.pone.0089103.g002
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0.047 and 0.064 mg/ml) and ceftriaxone (MIC-values 0.002 mg/
ml for both isolates) as was H. influenzae (MIC-value 0.006 mg/ml).
All three S. aureus isolates were methicillin susceptible as well as
susceptible to clindamycin, gentamicin and TMP-SMX; three and
one of them were resistant to tetracycline and erythromycin
respectively.
A total of 28.2% (205/728) children reported antibiotic use
,48 h prior to sampling; most frequently administered antibiotics
were TMP-SMX (35.1%) and amoxicillin or ampicillin (45.9%).
Bacteria were significantly more frequently isolated among
children on antibiotics (13.1%, 26/199) compared to those who
reported no prior antibiotic use (7.3%, 37/510, p=0.015).
Case-fatality rates
For 14 children the final outcome could not be ascertained
because they were referred to a tertiary care center (n = 8) or left
the hospital before completion of treatment (n = 6). For 697
(98.0%) children hospital outcome was known: 58/697 (8.3%)
children died, of them 20 (34.5%) and 15 (25.9%) were diagnosed
with severe malaria and IBI respectively. CFR were significantly
higher among children with IBI (23.4%) versus severe malaria
(6.8%, p,0.001), none of the children with severe malaria/IBI co-
infection (n= 8) died. Among children with a positive RDT and
negative microscopy with signs of severe malaria 11/110 (10.0%)
died, of them six had IBI.
CFR for IBI was highest among children ,1 year of age
(52.9%, 9/17). Among children with bacteremia, deaths occurred
among children infected by S. pneumoniae (4/12), E. coli (4/8), NTS
(3/20), S. aureus (2/3) and N. meningitidis (1/2). None of the patients
with Salmonella Typhi bacteremia died. Among children with
confirmed and probable meningitis 4/10 (40.0%) died (three S.
pneumoniae, one N. meningitidis), while 8/46 (17.4%) children with
cerebral malaria died.
Discussion
The present study showed that, among children ill enough to be
admitted to rural health facilities in Burkina Faso, severe malaria
was the leading cause of morbidity (40% of admissions) and
mortality (one third of deaths). IBI were however not uncommon
and were associated with a significantly higher CFR compared to
malaria. The relative proportions of severe malaria and IBI in
febrile and/or severely ill children differed dramatically according
to the seasons as well as the bacterial pathogens isolated, with a
peak of severe malaria during the rainy season and a relative
increase of IBI (mainly due to NTS) shortly thereafter. High
resistance rates to first line antibiotics were observed, particularly
among Gram-negative pathogens.
This study has several limitations. First, a substantial proportion
of children fulfilling inclusion criteria was not included. As age and
mortality rate did not differ significantly, non-inclusion probably
occurred at random although the lower body temperatures may
suggest less severe disease in the non-included patients. Second,
blood cultures intrinsically have moderate sensitivity (e.g. 40–80%
in the case of typhoid fever [16]), which is further lowered by
antibiotic exposure prior to sampling. In the present study, the
first-line antibiotics used prior to sampling (ampicillin and TMP-
SMX) were mostly ineffective to the pathogens retrieved and the
percentage of bacteremia was higher among children who were on
antibiotics before sampling. Nevertheless, more susceptible and
fragile strains, like S. pneumoniae, may have been missed. Quality
indicators of the current blood culture system were satisfying: the
percentage of contaminants (3.7%) was acceptable and lower
compared to other studies performed in malaria endemic settings
(8–14.3%) [2,17–20]. Performance of a lumbar puncture was left
to the decision of the health care worker, and the actual number of
meningitis cases may have been higher as in only nineteen
children with clinical signs of cerebral malaria and/or meningitis a
lumbar puncture was performed. Health care workers in rural
Africa may be reluctant to perform a lumbar puncture because of
lack of experience, appropriate materials or microbiological
facilities. In addition, the case definition of severe malaria might
have been too stringent: indeed, some children may have been
erroneously excluded from the diagnosis of severe malaria as no
parasites were seen by microscopy, whereas the PfHRP2-detecting
RDT was positive. This was supported by the significantly higher
Table 4. Antibiotic resistance patterns of Enterobacteriaceae.
Non-typhoid
Salmonella Salmonella Typhi Shigella spp. Escherichia coli Klebsiella pneumoniae*
n=21 n=12 n=2 n=8 n=1
Antibiotic n (%) resistant isolates
Ampicillin 19 (90.5) 0 2 7 (87.5) 1
Chloramphenicol 19 (90.5) 10 (83.3) 1 2 (25.0) 1
TMP-SMX 19 (90.5) 10 (83.3) 2 6 (75.0) 1
MDR 19 (90.5) 0 NA NA NA
Nalidixic acid 1 (4.8) 0 0 NA NA
Ciprofloxacin NA NA 0 5 (62.5) 0
DCS 1 (4.8) 0 NA NA NA
ESBL confirmed 1 (4.8) 0 0 3 (37.5) 0
Azithromycin 0 0 0 NA NA
Gentamicin NA NA NA 4 (50.0) 0
Meropenem/Ertapenem NA NA NA 0 0
DCS = decreased ciprofloxacin susceptibility, ESBL = extended-spectrum beta-lactamase, MDR = multidrug resistant, NA = non applicable, TMP-SMX = trimethoprim-
sulfamethoxazole.
*Isolated from CSF.
doi:10.1371/journal.pone.0089103.t004
Malaria and Bacterial Infections among Children
PLOS ONE | www.plosone.org 6 February 2014 | Volume 9 | Issue 2 | e89103
proportion of antimalarial treatment prior to admission in this
group compared to microscopy positive children. The frequent use
of TMP-SMX (which is an antimalarial as well [21]) prior to
admission may have further contributed to negative microscopy.
On the other hand, some children may have had asymptomatic
carriage of P. falciparum parasites, which is not uncommon in
Burkina Faso [22], while being ill due to a bacterial or viral
infection [23,24]. Furthermore, with the available diagnostic
methods we could not establish a final diagnosis for all children
included. Finally, the limited number of children for whom HIV
testing was performed precluded assessment of associations with
IBI and/or severe malaria.
Bacterial co-infections among children with severe malaria were
less frequent (2.7%) compared to those reported from other studies
(4.6%–8.3.%) [2,17,25–29] as was P. falciparum co-infection among
children with bacteremia (11.1% versus 14.7%–21.6%) [2,19,30].
This may be explained by the frequent use of antimalarial
treatment before admission. When considering positive RDT
results, the proportion of co-infections was substantially higher
(49.2% of children with bacteremia had positive RDT), and
comparable to a recent study from Tanzania (56.9%) [28].
Except for surveillance of meningitis epidemics and a single
study on blood culture isolates in a tertiary care urban center [31],
there are no previous data about the burden of community
acquired bacteremia in Burkina Faso, in particular from rural
areas. The high proportion of NTS isolates is consistent with
studies performed in other rural malaria endemic settings in sub-
Saharan Africa [18,19,26–29,32], although we isolated NTS
mainly after instead of during the rainy season [18,26,27].
Salmonella Typhi was relatively frequent in our study compared
to others performed in similar settings [2,32,33], possibly related to
specific local environmental conditions or to the inclusion of
children $5 years old. Although Salmonella Typhi is more common
in older children [16,28], it may also occur in children #5 [28,34]
as shown in the present study, and incidence rates of Salmonella
Typhi bacteremia have reported to be even higher among children
2–5 years compared to children $5 [35,36].
Resistance rates among community-acquired pathogens were
high, particularly among the Enterobacteriaceae. The high resistance
rates to the first line antibiotics TMP-SMX and amoxicillin/
ampicillin requires extension of surveillance studies to other
populations (e.g. adults, outpatients) and places in the country and
revision of the current national treatment guidelines. Of concern
are the findings of DCS and ESBL in one NTS isolate each and
especially the presence of ESBL with co-resistances to gentamicin
and fluoroquinolone antibiotics among E. coli, precluding treat-
ment options with commonly available antibiotics. All S.
pneumoniae, N. meningitidis and H. influenzae isolates were susceptible
to ceftriaxone, which is the recommended treatment for bacterial
meningitis in Burkina Faso.
CFR for IBI were significantly higher compared to severe
malaria (23.4% and 6.8% respectively) and existence of IBI as well
as appropriate case management should be more emphasized at all
levels of health care.
As malaria may predispose to NTS bacteremia [37,38],
reduction of malaria transmission would not only lead to a
reduction in morbidity and mortality due to malaria but could also
reduce the burden of NTS bacteremia [38]. As main reservoirs for
human invasive NTS have to date not been explored extensively
[39], containment of risk factors (malaria, HIV, malnutrition [39])
appears the best preventive measure. Introduction of the 13-
polyvalent pneumococcal vaccine and vaccination against typhoid
fever as well as improved hygiene could further reduce the burden
of community-acquired childhood bacteremia in this area.
In conclusion, although severe malaria was the main cause of
disease among children admitted to a rural hospital in Burkina
Faso, invasive bacterial infections were not uncommon and had
higher CFR. The high proportion and CFR of community
acquired bacteremia as well as the high antibiotic resistance rates
of the pathogens require improvement in hygiene, better
diagnostic methods and emphasize the need of blood culture
surveillance and revision of current treatment guidelines.
Acknowledgments
We thank clinical staff of CMA and Nanoro Health District for their
collaboration and for patient care and the laboratory staff of CRUN for
their contribution to the work.
Author Contributions
Conceived and designed the experiments: JM JJ HT. Performed the
experiments: JM IG BK PL BL. Analyzed the data: JM EB JJ. Contributed
reagents/materials/analysis tools: HT CVG JJ. Wrote the paper: JM JJ.
Coordinated patient enrollment: JM IG BK.
References
1. World Health Organization (2012) World malaria report 2012. World Health
Organization.
2. Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, et al. (2005) Bacteremia
among children admitted to a rural hospital in Kenya. N Engl J Med 352: 39–
47.
3. Reddy EA, Shaw AV, Crump JA (2010) Community-acquired bloodstream
infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis 10:
417–432.
4. Evans JA, Adusei A, Timmann C, May J, Mack D, et al. (2004) High mortality
of infant bacteraemia clinically indistinguishable from severe malaria. QJM 97:
591–597.
5. Crawley J, Chu C, Mtove G, Nosten F (2010) Malaria in children. Lancet 375:
1468–1481.
6. Gwer S, Newton CR, Berkley JA (2007) Over-diagnosis and co-morbidity of
severe malaria in African children: a guide for clinicians. Am J Trop Med Hyg
77: 6–13.
7. Institut National de la Statistique et de la De´mographie (INSD) et ICF
International (2012) Enqueˆte De´mographique et de Sante´ et a` Indicateurs
Multiples du Burkina Faso 2010. Calverton, Maryland, USA: INSD et ICF
International.
8. Minist re de la Sante (2012) Plan d’action 2013 du district sanitaire de Nanoro.
9. World Health Organization (1991) Basic Malaria Microscopy - Part I. Learner’s
Guide. World Health Organization.
10. CLSI (2013) Performance standards for antimicrobial susceptibility testing;
Twenty-second informational supplement. CLSI document M100-S23. Wayne,
PA: Clinical and Laboratory Standards Institute.
11. The European Commission on Antimicrobial Susceptibility Testing (2013)
Breakpoint tables for interpretation of MICs and zone diameters. Version 3.1.
12. Sjolund-Karlsson M, Joyce K, Blickenstaff K, Ball T, Haro J, et al. (2011)
Antimicrobial susceptibility to azithromycin among Salmonella enterica isolates
from the United States. Antimicrob Agents Chemother 55: 3985–3989.
13. Grimont F, Lejay-Collin M, Talukder KA, Carle I, Issenhuth S, et al. (2007)
Identification of a group of shigella-like isolates as Shigella boydii 20. J Med
Microbiol 56: 749–754.
14. World Health Organization (2000) Severe falciparum malaria. World Health
Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 94
Suppl 1: S1–90.
15. American Heart Association (2006)Pediatric advanced Life Support. American
Hearth Association. 273 p.
16. Bhutta ZA (2006) Current concepts in the diagnosis and treatment of typhoid
fever. BMJ 333: 78–82.
17. Bassat Q, Guinovart C, Sigauque B, Mandomando I, Aide P, et al. (2009) Severe
malaria and concomitant bacteraemia in children admitted to a rural
Mozambican hospital. Trop Med Int Health 14: 1011–1019.
18. Enwere G, Biney E, Cheung YB, Zaman SM, Okoko B, et al. (2006)
Epidemiologic and clinical characteristics of community-acquired invasive
bacterial infections in children aged 2–29 months in The Gambia. Pediatr
Infect Dis J 25: 700–705.
Malaria and Bacterial Infections among Children
PLOS ONE | www.plosone.org 7 February 2014 | Volume 9 | Issue 2 | e89103
19. Nielsen MV, Sarpong N, Krumkamp R, Dekker D, Loag W, et al. (2012)
Incidence and characteristics of bacteremia among children in rural Ghana.
PLoS One 7: e44063.
20. Sigauque B, Roca A, Mandomando I, Morais L, Quinto L, et al. (2009)
Community-acquired bacteremia among children admitted to a rural hospital in
Mozambique. Pediatr Infect Dis J 28: 108–113.
21. Manyando C, Njunju EM, D’Alessandro U, Van Geertruyden JP (2013) Safety
and efficacy of co-trimoxazole for treatment and prevention of Plasmodium
falciparum malaria: a systematic review. PLoS One 8: e56916.
22. Geiger C, Agustar HK, Compaore G, Coulibaly B, Sie A, et al. (2013) Declining
malaria parasite prevalence and trends of asymptomatic parasitaemia in a
seasonal transmission setting in North-Western Burkina Faso between 2000 and
2009–2012. Malar J 12: 27.
23. Hendriksen IC, White LJ, Veenemans J, Mtove G, Woodrow C, et al. (2013)
Defining falciparum-malaria-attributable severe febrile illness in moderate-to-
high transmission settings on the basis of plasma PfHRP2 concentration. J Infect
Dis 207: 351–361.
24. Mallewa M, Vallely P, Faragher B, Banda D, Klapper P, et al. (2013) Viral CNS
infections in children from a malaria-endemic area of Malawi: a prospective
cohort study. The Lancet Global Health 1.
25. Berkley JA, Bejon P, Mwangi T, Gwer S, Maitland K, et al. (2009) HIV
infection, malnutrition, and invasive bacterial infection among children with
severe malaria. Clin Infect Dis 49: 336–343.
26. Mabey DC, Brown A, Greenwood BM (1987) Plasmodium falciparum malaria
and Salmonella infections in Gambian children. J Infect Dis 155: 1319–1321.
27. Bronzan RN, Taylor TE, Mwenechanya J, Tembo M, Kayira K, et al. (2007)
Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV
coinfection, and outcome. J Infect Dis 195: 895–904.
28. Mtove G, Amos B, von SL, Hendriksen I, Mwambuli A, et al. (2010) Invasive
salmonellosis among children admitted to a rural Tanzanian hospital and a
comparison with previous studies. PLoS One 5: e9244.
29. Nadjm B, Mtove G, Amos B, Walker NF, Diefendal H, et al. (2012) Severe
febrile illness in adult hospital admissions in Tanzania: a prospective study in an
area of high malaria transmission. Trans R Soc Trop Med Hyg 106: 688–695.
30. Blomberg B, Manji KP, Urassa WK, Tamim BS, Mwakagile DS, et al. (2007)
Antimicrobial resistance predicts death in Tanzanian children with bloodstream
infections: a prospective cohort study. BMC Infect Dis 7: 43.
31. Ouedraogo AS, Dakoure-Kissou A, Poda GE, Koueta F, Ye-Ouattara D, et al.
(2011) Epidemiology, microbiology, and outcomes of septicemia in children
treated at the Charles de Gaulle University Pediatric Hospital in Burkina Faso.
Sante 21: 221–225.
32. Bahwere P, Levy J, Hennart P, Donnen P, Lomoyo W, et al. (2001) Community-
acquired bacteremia among hospitalized children in rural central Africa. Int J
Infect Dis 5: 180–188.
33. Brent AJ, Ahmed I, Ndiritu M, Lewa P, Ngetsa C, et al. (2006) Incidence of
clinically significant bacteraemia in children who present to hospital in Kenya:
community-based observational study. Lancet 367: 482–488.
34. Lunguya O, Lejon V, Phoba MF, Bertrand S, Vanhoof R, et al. (2012)
Salmonella typhi in the democratic republic of the congo: fluoroquinolone
decreased susceptibility on the rise. PLoS Negl Trop Dis 6: e1921.
35. Breiman RF, Cosmas L, Njuguna H, Audi A, Olack B, et al. (2012) Population-
based incidence of typhoid fever in an urban informal settlement and a rural
area in Kenya: implications for typhoid vaccine use in Africa. PLoS One 7:
e29119.
36. Marks F, Adu-Sarkodie Y, Hunger F, Sarpong N, Ekuban S, et al. (2010)
Typhoid fever among children, Ghana. Emerg Infect Dis 16: 1796–1797.
37. Cunnington AJ, de Souza JB, Walther M, Riley EM (2012) Malaria impairs
resistance to Salmonella through heme- and heme oxygenase-dependent
dysfunctional granulocyte mobilization. Nat Med 18: 120–127.
38. Scott JA, Berkley JA, Mwangi I, Ochola L, Uyoga S, et al. (2011) Relation
between falciparum malaria and bacteraemia in Kenyan children: a population-
based, case-control study and a longitudinal study. Lancet 378: 1316–1323.
39. Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA (2012)
Invasive non-typhoidal salmonella disease: an emerging and neglected tropical
disease in Africa. Lancet 379: 2489–2499.
Malaria and Bacterial Infections among Children
PLOS ONE | www.plosone.org 8 February 2014 | Volume 9 | Issue 2 | e89103
